Literature DB >> 32894418

Internet-Delivered Cognitive Behavioral Therapy and Psychoeducation Program for Patients with Gastrointestinal Stromal Tumors.

Edelmira Berenice Carbajal-López1, Dehisy Marisol Juárez-García2,3, Absalón Espinoza-Velazco4, German Calderillo-Ruiz5.   

Abstract

Gastrointestinal stromal tumors (GIST) account for 0.2-3% of all cancer diagnoses and are thus considered a rare type of cancer. Severe levels of fatigue occur in 33% of patients on imatinib, but besides treatment, fatigue is also associated with psychological distress. As far as we know, only one previous study has reported on the design of a psychoeducational intervention for caregivers and patients with GIST. The current study was conducted to compare the preliminary effectiveness of an Internet-delivered cognitive behavioral stress management intervention and psychoeducation program for anxiety, depression, fatigue, and quality of life in patients with gastrointestinal stromal tumors (GIST). This study had an experimental pre-test post-test design with a control group. Ninety-nine patients were randomly allocated to an Internet-delivered cognitive program (n = 50) or psychoeducation control group (n = 49). Participants completed the questionnaires at three time points (pre-test, post-test, and 3-month follow-up). Twenty-seven participants completed the intervention. A significant interaction effect between groups and time was found for general fatigue [F(2, 28) = 8.2, p < 0.001, ƞ2p = 0.25], reduced motivation [F(2, 28) = 3.5, p < 0.05, ƞ2p = 0.12], distress [F(2, 28) = 3.4, p < 0.05, ƞ2p = 0.12], and global health status [F(2, 28) = 3.8, p < 0.05, ƞ2p = 0.13]. Both intervention programs showed reductions in the dimensions of fatigue and improvements in distress and dimensions of quality of life. Additional research on a larger sample size is needed to confirm the effects obtained in this study.
© 2020. American Association for Cancer Education.

Entities:  

Keywords:  Gastrointestinal stromal tumors (GIST); Internet-delivered cognitive behavioral therapy; Psychoeducation program

Mesh:

Year:  2022        PMID: 32894418     DOI: 10.1007/s13187-020-01866-3

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   1.771


  6 in total

1.  Brief cognitive-behavioral and relaxation training interventions for breast cancer: A randomized controlled trial.

Authors:  Lisa M Gudenkauf; Michael H Antoni; Jamie M Stagl; Suzanne C Lechner; Devika R Jutagir; Laura C Bouchard; Bonnie B Blomberg; Stefan Glück; Robert P Derhagopian; Gladys L Giron; Eli Avisar; Manuel A Torres-Salichs; Charles S Carver
Journal:  J Consult Clin Psychol       Date:  2015-05-04

2.  Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial.

Authors:  Marieke van de Wal; Belinda Thewes; Marieke Gielissen; Anne Speckens; Judith Prins
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

3.  Developing and implementing a local education and support program for patients with gastrointestinal stromal tumors (GISTs).

Authors:  Marilee Kuhrik; Nancy S Kuhrik; Teresa L Deshields; JoAnn O'Neill; Beth Zubal
Journal:  J Cancer Educ       Date:  2010-12       Impact factor: 2.037

4.  Fear of progression in patients with gastrointestinal stromal tumors (GIST): Is extended lifetime related to the Sword of Damocles?

Authors:  José A E Custers; Ronald Tielen; Judith B Prins; Johannes H W de Wilt; Marieke F M Gielissen; Winette T A van der Graaf
Journal:  Acta Oncol       Date:  2015-03-03       Impact factor: 4.089

5.  Effectiveness of psycho-educational interventions with telecommunication technologies on emotional distress and quality of life of adult cancer patients: a systematic review.

Authors:  Ana Bártolo; Emelda Pacheco; Fabiana Rodrigues; Anabela Pereira; Sara Monteiro; Isabel M Santos
Journal:  Disabil Rehabil       Date:  2017-12-07       Impact factor: 3.033

Review 6.  Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours on behalf of the EORTC Quality of Life Group.

Authors:  Samantha C Sodergren; Alice White; Fabio Efficace; Mirjam Sprangers; Deborah Fitzsimmons; Andrew Bottomley; Colin D Johnson
Journal:  Crit Rev Oncol Hematol       Date:  2014-01-17       Impact factor: 6.312

  6 in total
  2 in total

Review 1.  Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature.

Authors:  Deborah van de Wal; Mai Elie; Axel Le Cesne; Elena Fumagalli; Dide den Hollander; Robin L Jones; Gloria Marquina; Neeltje Steeghs; Winette T A van der Graaf; Olga Husson
Journal:  Cancers (Basel)       Date:  2022-04-05       Impact factor: 6.639

2.  Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data.

Authors:  Dide den Hollander; Anne R Dirkson; Suzan Verberne; Wessel Kraaij; Gerard van Oortmerssen; Hans Gelderblom; Astrid Oosten; Anna K L Reyners; Neeltje Steeghs; Winette T A van der Graaf; Ingrid M E Desar; Olga Husson
Journal:  Support Care Cancer       Date:  2022-03-02       Impact factor: 3.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.